FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090902932> ?p ?o ?g. }

• W2090902932 endingPage "3984" @default.
• W2090902932 startingPage "3978" @default.
• W2090902932 abstract "Multipeptide vaccines for melanoma may cause inflammatory adverse events (IAE). We hypothesize that IAE are associated with a higher rate of immune response (IR) to vaccination and improved clinical outcomes. Adult patients with resected, high-risk (stage IIB to IV) melanoma were vaccinated with a combination of 12 class I major histocompatibility complex (MHC)-restricted melanoma epitopes, and IAE were recorded. A separate category for hypopigmentation (vitiligo) was also assessed. CD8+ T cell IR was assessed by direct interferon gamma ELISpot analysis. Overall survival and disease-free survival were analyzed by Cox proportional hazard modeling. Out of 332 patients, 57 developed IAE, the majority of which were dermatologic (minimum Common Terminology Criteria for Adverse Events [CTCAE] grade 3). Most nondermatologic IAE were CTCAE grade 1 and 2. Vitiligo developed in 23 patients (7 %). A total of 174 patients (53 %) developed a CD8+ response. Presence of IAE was significantly associated with development of IR (70 vs. 49 %, p = 0.005) and with disease-free survival (hazard ratio 0.54, p = 0.043). There were no significant associations relating vitiligo or IR alone with clinical outcomes. IAE are associated with a higher rate of CD8+ T cell response after vaccination therapy for high-risk melanoma. Our findings suggest either that antitumor activity induced by class I MHC-restricted peptide vaccines may depend on immunologic effects beyond simple expansion of CD8+ T cells or that the intrinsic inflammatory response of patients contributes to clinical outcome in melanoma." @default.
• W2090902932 created "2016-06-24" @default.
• W2090902932 creator A5021842242 @default.
• W2090902932 creator A5044113149 @default.
• W2090902932 creator A5050414062 @default.
• W2090902932 creator A5072314507 @default.
• W2090902932 creator A5072608226 @default.
• W2090902932 creator A5090865977 @default.
• W2090902932 date "2014-05-20" @default.
• W2090902932 modified "2023-09-23" @default.
• W2090902932 title "Inflammatory Adverse Events are Associated with Disease-Free Survival after Vaccine Therapy among Patients with Melanoma" @default.
• W2090902932 cites W1889451488 @default.
• W2090902932 cites W1918446688 @default.
• W2090902932 cites W1950572133 @default.
• W2090902932 cites W1967577151 @default.
• W2090902932 cites W1969434347 @default.
• W2090902932 cites W2002250199 @default.
• W2090902932 cites W2035907948 @default.
• W2090902932 cites W2038632547 @default.
• W2090902932 cites W2053876196 @default.
• W2090902932 cites W2055238647 @default.
• W2090902932 cites W2057345517 @default.
• W2090902932 cites W2060406878 @default.
• W2090902932 cites W2072169083 @default.
• W2090902932 cites W2072278160 @default.
• W2090902932 cites W2074365784 @default.
• W2090902932 cites W2089401318 @default.
• W2090902932 cites W2093385116 @default.
• W2090902932 cites W2095826876 @default.
• W2090902932 cites W2097995306 @default.
• W2090902932 cites W2109585496 @default.
• W2090902932 cites W2115541330 @default.
• W2090902932 cites W2136126826 @default.
• W2090902932 cites W2139863489 @default.
• W2090902932 cites W2142446193 @default.
• W2090902932 cites W2143131360 @default.
• W2090902932 cites W2145513156 @default.
• W2090902932 cites W2152155935 @default.
• W2090902932 cites W2159859852 @default.
• W2090902932 cites W2162771736 @default.
• W2090902932 cites W2162937174 @default.
• W2090902932 cites W2164218541 @default.
• W2090902932 cites W2325084969 @default.
• W2090902932 cites W4241141024 @default.
• W2090902932 cites W4375940934 @default.
• W2090902932 doi "https://doi.org/10.1245/s10434-014-3794-3" @default.
• W2090902932 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4192070" @default.
• W2090902932 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24841355" @default.
• W2090902932 hasPublicationYear "2014" @default.
• W2090902932 type Work @default.
• W2090902932 sameAs 2090902932 @default.
• W2090902932 citedByCount "7" @default.
• W2090902932 countsByYear W20909029322016 @default.
• W2090902932 countsByYear W20909029322018 @default.
• W2090902932 countsByYear W20909029322021 @default.
• W2090902932 crossrefType "journal-article" @default.
• W2090902932 hasAuthorship W2090902932A5021842242 @default.
• W2090902932 hasAuthorship W2090902932A5044113149 @default.
• W2090902932 hasAuthorship W2090902932A5050414062 @default.
• W2090902932 hasAuthorship W2090902932A5072314507 @default.
• W2090902932 hasAuthorship W2090902932A5072608226 @default.
• W2090902932 hasAuthorship W2090902932A5090865977 @default.
• W2090902932 hasBestOaLocation W20909029321 @default.
• W2090902932 hasConcept C126322002 @default.
• W2090902932 hasConcept C143998085 @default.
• W2090902932 hasConcept C167672396 @default.
• W2090902932 hasConcept C197934379 @default.
• W2090902932 hasConcept C203014093 @default.
• W2090902932 hasConcept C207103383 @default.
• W2090902932 hasConcept C2777658100 @default.
• W2090902932 hasConcept C2777793932 @default.
• W2090902932 hasConcept C2779053233 @default.
• W2090902932 hasConcept C2779980618 @default.
• W2090902932 hasConcept C44249647 @default.
• W2090902932 hasConcept C502942594 @default.
• W2090902932 hasConcept C71924100 @default.
• W2090902932 hasConcept C8891405 @default.
• W2090902932 hasConceptScore W2090902932C126322002 @default.
• W2090902932 hasConceptScore W2090902932C143998085 @default.
• W2090902932 hasConceptScore W2090902932C167672396 @default.
• W2090902932 hasConceptScore W2090902932C197934379 @default.
• W2090902932 hasConceptScore W2090902932C203014093 @default.
• W2090902932 hasConceptScore W2090902932C207103383 @default.
• W2090902932 hasConceptScore W2090902932C2777658100 @default.
• W2090902932 hasConceptScore W2090902932C2777793932 @default.
• W2090902932 hasConceptScore W2090902932C2779053233 @default.
• W2090902932 hasConceptScore W2090902932C2779980618 @default.
• W2090902932 hasConceptScore W2090902932C44249647 @default.
• W2090902932 hasConceptScore W2090902932C502942594 @default.
• W2090902932 hasConceptScore W2090902932C71924100 @default.
• W2090902932 hasConceptScore W2090902932C8891405 @default.
• W2090902932 hasIssue "12" @default.
• W2090902932 hasLocation W20909029321 @default.
• W2090902932 hasLocation W20909029322 @default.
• W2090902932 hasLocation W20909029323 @default.
• W2090902932 hasLocation W20909029324 @default.
• W2090902932 hasOpenAccess W2090902932 @default.
• W2090902932 hasPrimaryLocation W20909029321 @default.

• next